
Global Artesunate Injection Market Research Report by Purity (Artesunate 0.99, Artesunate 0.98), by Application (Malaria, Severe Malaria, Cerebral Malaria, Uncomplicated Malaria, Other Applications), by End User (Hospitals, Clinics, Pharmacies, Government
Description
As of 2023, the global artesunate injection market generated revenues close to USD 85 million, and is expected to have expansion with a compound annual growth rate (CAGR) of 0.9% from 2024 to 2032. This market is largely driven by the growing number of malaria cases worldwide, increased demand for immediate-response injectable treatments, and ongoing improvements in production and distribution frameworks. Efforts to raise public awareness and encourage early treatment have further strengthened the market foundation.
Nevertheless, the market faces notable obstacles. The cost of artesunate injections remains high, and limited availability in certain regions continues to restrict access. Lengthy and complex regulatory approval processes slow product rollout. Patent disputes and intellectual property concerns, coupled with competition from other antimalarial drugs, further challenge market expansion.
Telemedicine advancements allow for more timely and widespread diagnosis and treatment, especially in underserved rural areas. Growing public-private partnerships are injecting essential funding into malaria research. Regional manufacturing initiatives are improving supply chain efficiency, while the development of healthcare infrastructure across emerging economies is facilitating broader access. These combined forces influence pricing models, stabilize demand, and pave the way for a more resilient and accessible artesunate injection market in the coming years.
Market segmentations Insights
Based on the purity type, the global artesunate injection market has been segmented into Artesunate 0.98 and Artesunate 0.99.
The application type of the global artesunate injection market comprises cerebral malaria, malaria, uncomplicated malaria, severe malaria, other applications.
Depending on the end user, the global market is divided into hospitals, clinics, pharmacies, government institutions, non-governmental organizations.
Based on the distribution channel, the global artesunate injection market has been categorized into direct sales, distributors and wholesalers, retail pharmacies, and online sales.
In terms of regions, the global market is segmented, such as Europe, South America, North America, Middle East & Africa, and Asia Pacific.
Regional Insights
North America’s artesunate injection market is shaped by heightened concern over global infectious diseases like malaria. While the U.S. and Canada are not malaria-endemic, increasing cases among international travelers have driven the demand for reliable and fast-acting treatments such as artesunate to manage these imported infections effectively.
In Europe, the European Medicines Agency (EMA) has endorsed artesunate as a reliable treatment for severe malaria. As a result, it has been added to several national treatment frameworks. Despite this progress, widespread usage remains limited due to rigorous regulatory systems and the relatively high costs associated with the drug’s administration.
Across the Asia-Pacific region, the World Health Organization (WHO) has played a major role in encouraging the use of artesunate, leading to its widespread inclusion in national malaria treatment plans. The region’s ongoing fight against malaria has made artesunate increasingly essential.
South American countries located in malaria-prone regions like the Amazon, particularly Brazil, Colombia, and Peru, continue to rely on artesunate as part of their core antimalarial strategies, given its effectiveness in treating severe cases.
In Central Africa, especially in nations like the Democratic Republic of the Congo (DRC), artesunate is considered a critical component in the healthcare system, helping manage one of the world’s highest malaria burdens.
Key Companies
Intas Pharmaceutical, Systacare Remedies, Lexicare Pharma, AMIVAS, Advacare Pharma, Zydus Cadila, Cipla, Guilin Pharma, IPCA Laboratories, Watran Pharmaceuticals Pvt. Ltd. are the leading companies in the Global Artesunate Injection Market Research.
Nevertheless, the market faces notable obstacles. The cost of artesunate injections remains high, and limited availability in certain regions continues to restrict access. Lengthy and complex regulatory approval processes slow product rollout. Patent disputes and intellectual property concerns, coupled with competition from other antimalarial drugs, further challenge market expansion.
Telemedicine advancements allow for more timely and widespread diagnosis and treatment, especially in underserved rural areas. Growing public-private partnerships are injecting essential funding into malaria research. Regional manufacturing initiatives are improving supply chain efficiency, while the development of healthcare infrastructure across emerging economies is facilitating broader access. These combined forces influence pricing models, stabilize demand, and pave the way for a more resilient and accessible artesunate injection market in the coming years.
Market segmentations Insights
Based on the purity type, the global artesunate injection market has been segmented into Artesunate 0.98 and Artesunate 0.99.
The application type of the global artesunate injection market comprises cerebral malaria, malaria, uncomplicated malaria, severe malaria, other applications.
Depending on the end user, the global market is divided into hospitals, clinics, pharmacies, government institutions, non-governmental organizations.
Based on the distribution channel, the global artesunate injection market has been categorized into direct sales, distributors and wholesalers, retail pharmacies, and online sales.
In terms of regions, the global market is segmented, such as Europe, South America, North America, Middle East & Africa, and Asia Pacific.
Regional Insights
North America’s artesunate injection market is shaped by heightened concern over global infectious diseases like malaria. While the U.S. and Canada are not malaria-endemic, increasing cases among international travelers have driven the demand for reliable and fast-acting treatments such as artesunate to manage these imported infections effectively.
In Europe, the European Medicines Agency (EMA) has endorsed artesunate as a reliable treatment for severe malaria. As a result, it has been added to several national treatment frameworks. Despite this progress, widespread usage remains limited due to rigorous regulatory systems and the relatively high costs associated with the drug’s administration.
Across the Asia-Pacific region, the World Health Organization (WHO) has played a major role in encouraging the use of artesunate, leading to its widespread inclusion in national malaria treatment plans. The region’s ongoing fight against malaria has made artesunate increasingly essential.
South American countries located in malaria-prone regions like the Amazon, particularly Brazil, Colombia, and Peru, continue to rely on artesunate as part of their core antimalarial strategies, given its effectiveness in treating severe cases.
In Central Africa, especially in nations like the Democratic Republic of the Congo (DRC), artesunate is considered a critical component in the healthcare system, helping manage one of the world’s highest malaria burdens.
Key Companies
Intas Pharmaceutical, Systacare Remedies, Lexicare Pharma, AMIVAS, Advacare Pharma, Zydus Cadila, Cipla, Guilin Pharma, IPCA Laboratories, Watran Pharmaceuticals Pvt. Ltd. are the leading companies in the Global Artesunate Injection Market Research.
Table of Contents
107 Pages
- 1 Executive Summary
- 2 Market Introduction
- 2.1 Definition
- 2.2 Scope Of The Study
- 2.3 Research Objective
- 2.4 Market Structure
- 3 Research Methodology
- 3.1 Overview
- 3.2 Data Flow
- 3.2.1 Data Mining Process
- 3.3 Purchased Database:
- 3.4 Secondary Sources:
- 3.4.1 Secondary Research Data Flow:
- 3.5 Primary Research:
- 3.5.1 Primary Research Data Flow:
- 3.5.2 Primary Research: Number Of Interviews Conducted
- 3.5.3 Primary Research: Regional Coverage
- 3.6 Approaches For Market End User Estimation:
- 3.6.1 Revenue Analysis Approach
- 3.6.2 Data Forecasting
- 3.6.3 Data Forecasting Technique
- 3.7 Data Modeling
- 3.7.1 Microeconomic Factor Analysis:
- 3.7.2 Data Modeling:
- 3.8 Teams And Analyst Contribution
- 4 Market Dynamics
- 4.1 Introduction
- 4.2 Drivers
- 4.2.1 Increasing Prevalence Of Malaria
- 4.2.2 Growing Demand For Injectable Treatments
- 4.2.3 Advancements In Manufacturing And Distribution
- 4.2.4 Growing Awareness And Education
- 4.3 Restraints
- 4.3.1 High Cost Of Artesunate Injections
- 4.3.2 Limited Availability In Certain Regions
- 4.3.3 Regulatory Challenges And Lengthy Approval Processes
- 4.3.4 Intellectual Property And Patent Issues
- 4.3.5 Competing Antimalarial Therapies
- 4.4 Opportunity
- 4.4.1 Expansion Of Telehealth Services For Remote Diagnosis And Treatment
- 4.4.2 Increased Public-private Partnerships For Funding Malaria Research
- 4.4.3 Development Of Combination Therapies To Enhance Treatment Efficacy
- 4.4.4 Emergence Of Regional Manufacturing Hubs To Boost Supply Chain Resilience
- 4.4.5 Impact On Overall Healthcare Sector
- 4.4.6 Impact On Global Artesunate Injection Market
- 4.4.7 Impact On The Supply Chain Of The Artesunate Injection Market
- 4.4.8 Impact On Market Demand Of Artesunate Injection Market
- 4.4.9 Impact On Pricing Of Artesunate Injection Market
- 5 Market Factor Analysis
- 5.1 Supply Chain Analysis
- 5.1.1 Raw Material Suppliers
- 5.1.2 Manufacturing
- 5.1.3 Distribution And Logistics
- 5.1.4 Retail And Consumption
- 5.2 Porter’s Five Forces Model
- 5.2.1 Bargaining Power Of Suppliers
- 5.2.2 Bargaining Power Of Buyers
- 5.2.3 Threat Of New Entrants
- 5.2.4 Threat Of Substitutes
- 5.2.5 Intensity Of Rivalry
- 6 Global Artesunate Injection Market, By Purity
- 6.1 Introduction
- 6.2 Artesunate 0.99
- 6.3 Artesunate 0.98
- 7 Global Artesunate Injection Market, By Application
- 7.1 Introduction
- 7.1.1 Malaria
- 7.1.2 Severe Malaria
- 7.1.3 Cerebral Malaria
- 7.1.4 Uncomplicated Malaria
- 8 Global Artesunate Injection Market, By End User
- 8.1 Introduction
- 8.1.1 Hospitals
- 8.1.2 Clinics
- 8.1.3 Pharmacies
- 8.1.4 Government Institutions
- 8.1.5 Non-governmental Organizations
- 9 Global Artesunate Injection Market, By Distribution Channel
- 9.1 Introduction
- 9.1.1 Direct Sales
- 9.1.2 Distributors And Wholesalers
- 9.1.3 Retail Pharmacies
- 9.1.4 Online Sales
- 10 Global Artesunate Injection Market, By Region
- 10.1 Overview
- 10.2 North America
- 10.3 Europe
- 10.4 Asia Pacific
- 10.5 South America
- 10.6 Middle East & Africa
- 11 Competitive Landscape
- 11.1 Introduction
- 11.2 Market Share Analysis, 2023
- 11.3 Competitor Dashboard
- 11.4 Key Developments & Growth Strategies
- 11.4.1 Launch Developments
- 12 Company Profiles
- 12.1 Amivas
- 12.1.1 Company Overview
- 12.1.2 Types Offered
- 12.1.3 Swot Analysis
- 12.1.4 Key Strategy
- 12.2 Advacare Pharma
- 12.2.1 Company Overview
- 12.2.2 Types Offered
- 12.2.3 Swot Analysis
- 12.2.4 Key Strategy
- 12.3 Zydus Cadila
- 12.3.1 Company Overview
- 12.3.2 Types Offered
- 12.3.3 Swot Analysis
- 12.3.4 Key Strategy
- 12.4 Intas Pharmaceutical
- 12.4.1 Company Overview
- 12.4.2 Types Offered
- 12.4.3 Swot Analysis
- 12.4.4 Key Strategy
- 12.5 Systacare Remedies
- 12.5.1 Company Overview
- 12.5.2 Types Offered
- 12.5.3 Swot Analysis
- 12.5.4 Key Strategy
- 12.6 Lexicare Pharma
- 12.6.1 Company Overview
- 12.6.2 Types Offered
- 12.6.3 Swot Analysis
- 12.7 Cipla
- 12.7.1 Company Overview
- 12.7.2 Types Offered
- 12.7.3 Swot Analysis
- 12.7.4 Key Strategy
- 12.8 Guilin Pharma
- 12.8.1 Company Overview
- 12.8.2 Types Offered
- 12.8.3 Swot Analysis
- 12.9 Ipca Laboratories
- 12.9.1 Company Overview
- 12.9.2 Types Offered
- 12.9.3 Swot Analysis
- 12.10 Watran Pharmaceuticals Pvt. Ltd
- 12.10.1 Company Overview
- 12.10.2 Types Offered
- 12.10.3 Swot Analysis 106
- List Of Tables
- Table 1 Global Artesunate Injection Market, By Purity, 2018-2032 (Usd)
- Table 2 Global Artesunate Injection Market, By Application, 2018-2032 (Usd)
- Table 3 Global Artesunate Injection Market, By End User, 2018-2032 (Usd)
- Table 4 Global Artesunate Injection Market, By Distribution Channel, 2018-2032 (Usd)
- Table 5 Global Artesunate Injection Market, By Region, 2018-2032 (Usd)
- Table 6 North America: Artesunate Injection Market, By Country, 2018-2032 (Usd)
- Table 7 North America Artesunate Injection Market, By Purity, 2018-2032 (Usd)
- Table 8 North America Artesunate Injection Market, By Application, 2018-2032 (Usd)
- Table 9 North America Artesunate Injection Market, By End User, 2018-2032 (Usd)
- Table 10 North America Artesunate Injection Market, Distribution Channel, 2018-2032 (Usd)
- Table 11 Us Artesunate Injection Market, By Purity, 2018-2032 (Usd )
- Table 12 Us: Artesunate Injection Market, By Application, 2018-2032 (Usd)
- Table 13 Us Artesunate Injection Market, By End User, 2018-2032 (Usd)
- Table 14 Us Artesunate Injection Market, By Distribution Channel, 2018-2032 (Usd)
- Table 15 Canada Artesunate Injection Market, By Purity, 2018-2032 (Usd )
- Table 16 Canada: Artesunate Injection Market, By Application, 2018-2032 (Usd )
- Table 17 Canada Artesunate Injection Market, By End User, 2018-2032 (Usd )
- Table 18 Canada Artesunate Injection Market, By Distribution Channel, 2018-2032 (Usd )
- Table 19 Europe: Artesunate Injection Market, By Country, 2018-2032 (Usd )
- Table 20 Europe Artesunate Injection Market, By Purity, 2018-2032 (Usd )
- Table 21 Europe: Artesunate Injection Market, By Application, 2018-2032 (Usd )
- Table 22 Europe Artesunate Injection Market, By End User, 2018-2032 (Usd )
- Table 23 Europe Artesunate Injection Market, By Distribution Channel, 2018-2032 (Usd )
- Table 24 Asia Pacific: Artesunate Injection Market, By Country, 2018-2032 (Usd )
- Table 25 Asia Pacific Artesunate Injection Market, By Purity, 2018-2032 (Usd )
- Table 26 Asia Pacific: Artesunate Injection Market, By Application, 2018-2032 (Usd )
- Table 27 Asia Pacific Artesunate Injection Market, By End User, 2018-2032 (Usd )
- Table 28 Asia Pacific Artesunate Injection Market, By Distribution Channel, 2018-2032 (Usd )
- Table 29 South America: Artesunate Injection Market, By Country, 2018-2032 (Usd )
- Table 30 South America Artesunate Injection Market, By Purity, 2018-2032 (Usd )
- Table 31 South America: Artesunate Injection Market, By Application, 2018-2032 (Usd )
- Table 32 South America Artesunate Injection Market, By End User, 2018-2032 (Usd )
- Table 33 South America Artesunate Injection Market, By Distribution Channel, 2018-2032 (Usd )
- Table 34 Middle East & Africa: Artesunate Injection Market, By Country, 2018-2032 (Usd )
- Table 35 Middle East & Africa Artesunate Injection Market, By Purity, 2018-2032 (Usd )
- Table 36 Middle East & Africa: Artesunate Injection Market, By Application, 2018-2032 (Usd )
- Table 37 Middle East & Africa Artesunate Injection Market, By End User, 2018-2032 (Usd )
- Table 38 Middle East & Africa Artesunate Injection Market, By Distribution Channel, 2018-2032 (Usd )
- Table 39 Launch Developments
- Table 40 Amivas: Product Offered
- Table 41 Advacare Pharma: Types Offered
- Table 42 Zydus Cadila: Types Offered
- Table 43 Intas Pharmaceutical: Types Offered
- Table 44 Systacare Remedies: Types Offered
- Table 45 Lexicare Pharma: Types Offered
- Table 46 Cipla: Types Offered
- Table 47 Guilin Pharma: Types Offered
- Table 48 Ipca Laboratories: Types Offered
- Table 49 Watran Pharmaceuticals Pvt. Ltd: Types Offered
- List Of Figures
- Figure 1 Global Artesunate Injection Market: Structure
- Figure 2 Global Artesunate Injection Market: Market Growth Factor Analysis (2023-2032)
- Figure 3 Driver Impact Analysis (2024-2032)
- Figure 4 Restraint Impact Analysis (2023-2032)
- Figure 5 Supply Chain Analysis: Global Artesunate Injection Market
- Figure 7 Porter’s Five Forces Model: Global Artesunate Injection Market
- Figure 8 Global Artesunate Injection Market, By Purity, Segment Attractiveness Analysis
- Figure 9 Global Artesunate Injection Market, By Purity, 2023 (% Share)
- Figure 10 Global Artesunate Injection Market, By Application, Segment Attractiveness Analysis
- Figure 11 Global Artesunate Injection Market, By Application, 2023 (% Share)
- Figure 12 Global Artesunate Injection Market, By End User, Segment Attractiveness Analysis
- Figure 13 Global Artesunate Injection Market, By End User, 2023 (% Share)
- Figure 14 Global Artesunate Injection Market, By Distribution Channel, Segment Attractiveness Analysis
- Figure 15 Global Artesunate Injection Market, By Distribution Channel, 2023 (% Share)
- Figure 16 Global Artesunate Injection Market, By Region, 2023 (% Share)
- Figure 17 North American Market: Swot Analysis
- Figure 18 North America: Artesunate Injection Market Share, By Country, 2023 (% Share)
- Figure 19 Europe Market: Swot Analysis
- Figure 20 Europe: Artesunate Injection Market Share, By Country, 2023 (% Share)
- Figure 21 Asia Pacific Market: Swot Analysis
- Figure 22 Asia Pacific: Artesunate Injection Market Share, By Country, 2023 (% Share)
- Figure 23 South America Market: Swot Analysis
- Figure 24 South America: Artesunate Injection Market Share, By Country, 2023 (% Share)
- Figure 25 Middle East & Africa Market: Swot Analysis
- Figure 26 Middle East & Africa: Artesunate Injection Market Share, By Country, 2023 (% Share)
- Figure 27 Global Artesunate Injection Players: Competitive Analsis, 2023
- Figure 28 Competitor Dashboard: Global Artesunate Injection
- Figure 29 Amivas: Swot Analysis
- Figure 30 Advacare Pharma: Swot Analysis
- Figure 31 Zydus Cadila: Swot Analysis
- Figure 32 Intas Pharmaceutical: Swot Analysis
- Figure 33 Systacare Remedies: Swot Analysis
- Figure 34 Lexicare Pharma: Swot Analysis
- Figure 35 Cipla: Swot Analysis
- Figure 36 Guilin Pharma: Swot Analysis
- Figure 37 Ipca Laboratories: Swot Analysis
- Figure 38 Watran Pharmaceuticals Pvt. Ltd: Swot Analysis 106
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.